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Abstract

The mechanism of T cell dysfunction induced by Diethylstilbestrol.
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Estrogens have the ability to alter the immune system. Diethylstilbestrol (DES), a
synthetic estrogen, is known to have estrogenic activity and induce thymic alterations.
We investigated the mechanism by which DES is able to alter T cells and thus the
immune system. First, we studied the effect of DES on mature T cells by using the T cell
leukemia cell line, Jurkat. We found that DES treatment reduced cell viability and
increased apoptosis. Additionally, apoptosis was found to involve both death receptor
and mitochondria1 pathways. Furthermore, estrogen receptor beta was found to be
expressed in these cells and increased following DES treatment. Secondly, we studied
the effect of DES on developing T cells using two different mouse models, timed

pregnant and HY-TCR transgenic. The pregnant mouse model showed that DES
exposure in utero reduced thymic cell viability and induced apoptosis at gestational day
(gd)-17. Apoptosis was found to involve the death receptor pathway. Additionally,
alterations in T cell subsets was most pronounced at gd-17 as well. The HY-TCR tg
mouse model showed that DES exposure altered both positive and negative selection of T
cells. Furthermore, DES was found to alter the ability of T cells to proliferate during an
immune response. Finally, we studied the intrathymic interaction between thymic
stromal cells and thymic T cells. We found that cel1:cell interaction was important for
inducing T cell apoptosis in the thymus. Additionally, FasL expression was increased on
thymic stromal cellsfollowing DES exposure. Furthermore, the presence of both FasL on
stromal cells and Fas on T cells was important for inducing T cell apoptosis in the
thymus.

Chapter I. Introduction

Immune system
The immune system is a network of heterogeneous cellular populations and
chemical signals (cytolunes, chemokines) (Arai et al., 1990). Immune cell types
represented include: myeloid (macrophage) and lymphoid cells (T cells and B cells).
These cells play roles in the generation of an immune response. There are two basic
types of immune responses, innate and cell-mediated (Dempsey et al., 2003). In the
innate response, preexisting immune components are directed against a foreign threat.
These responses do not need to be induced (pre-formed) and are nonspecific defenses.
These defensive mechanisms are numerous. Nonspecific defenses can be barriers
(mechanical, chemical, immunological, or genetic), inflammatory responses, fevers, and
interferon. Other mechanisms represented are complement and phagocytosis.
Mechanical barriers are typically found at entry points. These barriers are anatomical or
physiological such as skin, membranes (mucous), or cilia (Diamond et al., 2000;
Jameson, 2004). Chemical barriers are secreted molecules such as lysozyme or defensin
(Lehrer et al., 1993; Fellermann and Stange, 2001). Immunological barriers are normal
flora that reside in the body. Genetic barriers are guided by hereditary characteristics that
are specific for individuals (Kennedy, 1989; Wells et al., 2003).

Chapter 111. Induction of Apoptosis in T cells from Murine Fetal Thymus Following
Perinatal Exposure to Diethylstilbestrol

Abstract

Perinatal exposure to diethylstilbestrol (DES) is known to cause thymic atrophy in
mice although the precise mechanism remains unclear. In the current study we
investigated whether perinatal exposure to DES would trigger apoptosis in thymocytes.
To this end, C57BLl6 pregnant mice were injected intraperitoneally (ip) on gestational
day (gd) -15 and - 16 with 5pgIkg DES. Analysis of thymi harvested from mice on gd-17,
gd- 19 and postnatal day (PD) 1, showed a reduction in thymic cellularity on gd- 17,
increase on gd-19 and no significant change on PD-1. Additionally, DES treatment
significantly altered the proportion and absolute number of T-cell subsets, particularly on
gd-17 and -19. Apoptosis was increased in DES-treated thymocytes when compared to
the controls and was seen only on gd-17 but not on gd-19 or PD-1. Moreover, DEStreated gd-17 thymocytes had increased DEVDase activity. Microarray analysis of 96
apoptotic genes in gd-17 thymocytes revealed that exposure to DES increased the
expression of several apoptotic genes primarily belonging to tumor necrosis factor (TNF)
and TNF receptor (TNFR) family. Taken together, these results suggest that DESinduced thymic atrophy following perinatal exposure may result, at least in part, from
increased apoptosis mediated by death receptor pathway involving TNF family

